Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

"Prevalence and Outcome of Avascular Necrosis of the Hip (AVN) Among Young Omani Patients with Sickle Cell Disease"

Iman Al Fadhali, Farah Al-Kindy, MD, Naema Alshibli, Salam Alkindi, FRCP, BA, MBBChir, Murtadha Al-Khabori, MD, Abdulhakim Al Rawas, Asma Al Shezawi, Yasser Mahfouz, Surekha Tony Mevada, Yasser Wali

Blood (2019) 134 (Supplement_1): 3577.

https://doi.org/10.1182/blood-2019-127875

Published: 2019

Journal Articles

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Geoffrey Bourg, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Safiatou Diallo, MD, Sabine Amah, MD, Christine Devalck, MD, Catherine Heijmans, MD, Laurence Hanssens, MD, Rossana Pavone, MD, Malou Ngalula Mujinga, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2018-99-118373

Published: 2018

Journal Articles

The Effect of Health Care Disparities on Complications and Mortality in Sickle Cell Disease

Stuthi Pavani Perimbeti, MD MPH, Kevin Ye Hou, MD, Sabarina Ramanathan, MD, Adonas Woodard, MD, Daniel Kyung, MD, Qian Wang, MD MPH, Pamela Ann Crilley, DO, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 5886.

https://doi.org/10.1182/blood-2018-99-119961

Published: 2018

Journal Articles

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

Mohsen Saleh Elalfy, MD, Iman Fadhli, Shaimaa Mohammad, Aida Ali, Naema Shibli, Farah Kindi, Sultan Almaskari, Yasser Wali, MD

Blood (2018) 132 (Supplement 1): 4921.

https://doi.org/10.1182/blood-2018-99-116683

Published: 2018

Journal Articles

Spontaneous Healing of Avascular Necrosis of the Femoral Head in Sickle Cell Disease

Nelda Itzep, MD, Siddharth Jadhav, MD, Celeste K Kanne, BA, Vivien A Sheehan, MD PhD

Blood (2018) 132 (Supplement 1): 4924.

https://doi.org/10.1182/blood-2018-99-119328

Published: 2018

Journal Articles

A Vascular Necrosis of the Femoral Head Is It an Initial Presentation of CML or Consequences of Therapies (Interferon alpha and Tyrosine Kinase Inhibitors)

Mohamed A. Yassin, MBBS ,MSc,CABM,FACP, Nader I Al-Dewik, BSc, MSc, PhD, Abdulqadir Nashwan, Ashraf Tawfiq Soliman, MDPhD

Blood (2015) 126 (23): 5143.

https://doi.org/10.1182/blood.V126.23.5143.5143

Published: 2015

Journal Articles

Randomized Clinical Trial to Evaluate the Effect of Two Physical Therapy Programs in Musculoskeletal Dysfunction in Subjects with Sickle Cell Disease

Camila Zanoni, MSC, Fabio Galvao, MSc, Glenda Feldberg Andrade Pinto, BSc, Sara T O Saad, MD PhD

Blood (2014) 124 (21): 5982.

https://doi.org/10.1182/blood.V124.21.5982.5982

Published: 2014

Journal Articles

Low Bone Density In Sickle Cell Disease Is a Risk Factor in The Development Of Avascular Necrosis

Hassan A. Al-Jafar, MBChB , MD, Leena M Aytoglu, BSC - MSC ( Master in molecular medecine ), Jehan Al-Shemmari, PhD, Uzma Afzal, Iman Al-Shemmari, Saud Al-Enizi

Blood (2013) 122 (21): 4688.

https://doi.org/10.1182/blood.V122.21.4688.4688

Published: 2013

Journal Articles

Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

Rudy Chapusette, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, France Ziereisen, MD, Laurence Hanssens, MD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 2107.

https://doi.org/10.1182/blood.V120.21.2107.2107

Published: 2012

Journal Articles

Retrospective Analysis of Core Decompression in Avascular Necrosis of the Femoral Head in Patients with Sickle Cell Disease.

Austin Cail, Kavita Natrajan, MBBS, Nadine Barrett, FNP, Latanya Bowman, RN, Betsy Clair, Gloria Sayer, Carlos Isales, MD, Raymond Scott Corpe, MD, Abdullah Kutlar, MD

Blood (2012) 120 (21): 2108.

https://doi.org/10.1182/blood.V120.21.2108.2108

Published: 2012

Journal Articles

Non-Cardiopulmonary Factors Affecting the Six-Minute Walk Distance in Patients with Sickle Cell Disease: Results From the Walk-PHaSST Study

Blood (2011) 118 (21): 1074.

https://doi.org/10.1182/blood.V118.21.1074.1074

Published: 2011

Journal Articles

Evaluation of Possible Risk Factors for Avascular Necrosis of the Femoral head in patients with Sickle Cell Disease

Abdul Kareem Al-Momen, MD, FRCPC, Tarek Owaidah, MD, FRCPA, Nizar Naqshabandi, MBBS, FRCPC, Rana Hasanato, MBBS, MD, Sri-Halima Cana, MBBS, Abdul Qayum, MBBS, MD, Marwan Zamzami, MBBS, FRCSC, Aamer Aleem, MD

Blood (2010) 116 (21): 4819.

https://doi.org/10.1182/blood.V116.21.4819.4819

Published: 2010

Journal Articles

Prevalence of Sickle Cell Anemia In Eastern India

Abhijit Chakraborty, Jayasri Basak, Deboshree Majumdar, Soma Mukhopadhyay, Sagnik Chakraborty, Ashis Mukhopadhyay, Medical, Director, and, Medical, Oncologist

Blood (2010) 116 (21): 4822.

https://doi.org/10.1182/blood.V116.21.4822.4822

Published: 2010

Journal Articles

Stroke in Sickle Cell Anemia After Excellent Response to Hydroxyurea.

Ubaldo Martinez, MD, Samir K. Ballas, MD

Blood (2009) 114 (22): 4622.

https://doi.org/10.1182/blood.V114.22.4622.4622

Published: 2009

Journal Articles

Early Adjuvant Treatment after Risk-Adapted Autologous Stem Cell Transplant for Systemic Light-Chain Amyloidosis: Increased Hospitalizations and Impaired Immune Recovery but Improved Responses and Overall Survival.

James E. Hoffman, MD, Hani Hassoun, MD, Heather Landau, MD, Elizabeth Hoover, Adam Cohen, MD, Stephen Nimer, MD, Raymond Comenzo, MD

Blood (2008) 112 (11): 3329.

https://doi.org/10.1182/blood.V112.11.3329.3329

Published: 2008

Journal Articles

Hydroxyurea Use Is Associated with Avascular Necrosis of the Femoral Head among Children with Sickle Cell Disease

Kris Michael Mahadeo, M.D., Suzette Oyeku, M.D., Karen Moody, M.D., Swapmil N. Rajpathak, M.D., Dr.Ph, Abraham Groner, M.D., Ruth Santizo, B.S., M. Catherine Driscoll, MD

Blood (2008) 112 (11): 2477.

https://doi.org/10.1182/blood.V112.11.2477.2477

Published: 2008

Journal Articles

Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.

Abraham Avigdor, MD, Shlomo Bulvik, MD, Eldad Dann, MD, Itai Levi, MD, Galit Perez-Avraham, MD, Noga Shemtov, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Isaac Ben-Bassat, MD, Aaron Polliack, MD

Blood (2007) 110 (11): 2319.

https://doi.org/10.1182/blood.V110.11.2319.2319

Published: 2007

Journal Articles

Membrane Microparticles from Patients with Steroid-Induced Avascular Necrosis of Femoral Head Increase the Expression of Fas in Endothelial Cells In Vitro.

Xi-sheng Weng, MD, Zhi-hong Wu, MD., Yi Wei, MD., Gui-xing Qiu, MD

Blood (2007) 110 (11): 3903.

https://doi.org/10.1182/blood.V110.11.3903.3903

Published: 2007

Journal Articles

Beneficial Effect of Hydroxyurea on Avascular Necrosis of Femoral Head in Adult Sickle Cell Disease (Homozygous) - One Year Prospective Study in Orissa, India.

Rabindra Jena, MD, PhD, Trupti R. Swain, MD (Pharmacology)

Blood (2006) 108 (11): 3784.

https://doi.org/10.1182/blood.V108.11.3784.3784

Published: 2006

Journal Articles

Interruption of Bisphosphonates (BP) Therapy in Multiple Myeloma (MM) Patients and Osteonecrosis of the Jaw (ONJ).

Ashraf Badros, MD, Olga Goloubeva, PhD, Dianna Weikel, DDS, Aaron P. Rapoport, MD, Gorgun Akpek, MD, Saul Yanovich, MD, Timothy Meiller, DDS, PhD, Edward Sausville, MD, PhD

Blood (2006) 108 (11): 5026.

https://doi.org/10.1182/blood.V108.11.5026.5026

Published: 2006

NARROW

"Prevalence and Outcome of Avascular Necrosis of the Hip (AVN) Among Young Omani Patients with Sickle Cell Disease"

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

The Effect of Health Care Disparities on Complications and Mortality in Sickle Cell Disease

Avascular Necrosis of the Femoral Head in Sickle Cell Disease in Egypt and Oman: A Cross Sectional Study

Spontaneous Healing of Avascular Necrosis of the Femoral Head in Sickle Cell Disease

A Vascular Necrosis of the Femoral Head Is It an Initial Presentation of CML or Consequences of Therapies (Interferon alpha and Tyrosine Kinase Inhibitors)

Randomized Clinical Trial to Evaluate the Effect of Two Physical Therapy Programs in Musculoskeletal Dysfunction in Subjects with Sickle Cell Disease

Low Bone Density In Sickle Cell Disease Is a Risk Factor in The Development Of Avascular Necrosis

Reduction of the Six-Minute Walk Distance in Children with Sickle Cell Disease Is Correlated with Silent Infarct: Results From a Cross-Sectional Evaluation in a Single Center in Belgium.

Retrospective Analysis of Core Decompression in Avascular Necrosis of the Femoral Head in Patients with Sickle Cell Disease.

Non-Cardiopulmonary Factors Affecting the Six-Minute Walk Distance in Patients with Sickle Cell Disease: Results From the Walk-PHaSST Study

Evaluation of Possible Risk Factors for Avascular Necrosis of the Femoral head in patients with Sickle Cell Disease

Prevalence of Sickle Cell Anemia In Eastern India

Stroke in Sickle Cell Anemia After Excellent Response to Hydroxyurea.

Early Adjuvant Treatment after Risk-Adapted Autologous Stem Cell Transplant for Systemic Light-Chain Amyloidosis: Increased Hospitalizations and Impaired Immune Recovery but Improved Responses and Overall Survival.

Hydroxyurea Use Is Associated with Avascular Necrosis of the Femoral Head among Children with Sickle Cell Disease

Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.

Membrane Microparticles from Patients with Steroid-Induced Avascular Necrosis of Femoral Head Increase the Expression of Fas in Endothelial Cells In Vitro.

Beneficial Effect of Hydroxyurea on Avascular Necrosis of Femoral Head in Adult Sickle Cell Disease (Homozygous) - One Year Prospective Study in Orissa, India.

Interruption of Bisphosphonates (BP) Therapy in Multiple Myeloma (MM) Patients and Osteonecrosis of the Jaw (ONJ).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only